EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Imaging blood–brain barrier dysfunction in drug‐resistant epilepsy: A multi‐center feasibility study

Nir Cafri iD, Sheida Mirloo, Daniel Zarhin, Lyna Kamintsky, Yonatan Serlin, Laith Alhadeed, Ilan Goldberg, Mark A Maclean, Ben Whatley, Ilia Urman, Colin P Doherty, Chris Greene und 10 weitere

Epilepsia · 2025-01 · 66 (1) · 195-206

DOI: 10.1111/epi.18145 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Epilepsia, online erschienen am 06.11.2024. Verfasst von Nir Cafri und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Professor Vladimir Zelman Inter-Disciplinary Center of Brain Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Isra…. Hauptthemen laut MEDLINE: Drug Resistant Epilepsy, Blood-Brain Barrier, Brain. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Neurosurgery Research and Education Foundation, Irish Research Council, Canadian Institute of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Blood–brain barrier dysfunction (BBBD) has been linked to various neurological disorders, including epilepsy. This study aims to utilize dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI) to identify and compare brain regions with BBBD in patients with epilepsy (PWE) and healthy individuals.

Methods

We scanned 50 drug‐resistant epilepsy (DRE) patients and 58 control participants from four global specialized epilepsy centers using DCE‐MRI. The presence and extent of BBBD were analyzed and compared between PWE and healthy controls.

Results

Both greater brain volume and higher number of brain regions with BBBD were significantly present in PWE compared to healthy controls ( p < 10 −7 ). No differences in total brain volume with BBBD were observed in patients diagnosed with either focal seizures or generalized epilepsy, despite variations in the affected regions. Overall brain volume with BBBD did not differ in PWE with MRI‐visible lesions compared with non‐lesional cases. BBBD was observed in brain regions suspected to be related to the onset of seizures in 82% of patients ( n = 39) and was typically identified in, adjacent to, and/or in the same hemisphere as the suspected epileptogenic lesion ( n = 10). Significance These findings are consistent with pre‐clinical studies that highlight the role of BBBD in the development of DRE and identify microvascular stabilization as a potential therapeutic strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistant EpilepsyBlood-Brain BarrierBrainHumansFemaleMaleMagnetic Resonance ImagingAdultYoung AdultFeasibility StudiesMiddle AgedAdolescent

Stichwörter der Autor:innen

biomarkersblood–brain barrierdrug resistanceepilepsymagnetic resonance imaging

Autor:innen und Institutionen

  • Department of Physiology, Professor Vladimir Zelman Inter-Disciplinary Center of Brain Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Department of Cell Biology, Cognitive and Brain Sciences, Professor Vladimir Zelman Inter-Disciplinary Center of Brain Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Department of Neurology, Rabin Medical Center, Beilinson Hospital and Tel-Aviv University, Petah Tikva, Israel.
  • Department of Medical Neuroscience, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Neurophysiology of Epilepsy Unit, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, Maryland, USA.
  • Division of Neurosurgery, Dalhousie University, Halifax, Nova Scotia, Canada.

ORCID-Profile: Nir Cafri, Claire Behan, Matthias Koepp, Alon Friedman, Felix Benninger

Förderung

  • Neurosurgery Research and Education Foundation
  • Irish Research Council
  • Canadian Institute of Health Research
  • United States - Israel Binational Science Foundation
  • Network of European Funding for Neuroscience Research (NEURON ERA-NET)
  • Israel Science Foundation
  • Science Foundation Ireland
  • European Research Council

Zitieren

APA

Cafri, N., Mirloo, S., Zarhin, D., Kamintsky, L., Serlin, Y., Alhadeed, L., Goldberg, I., Maclean, M. A., Whatley, B., Urman, I., Doherty, C. P., Greene, C., Behan, C., Brennan, D., Campbell, M., Bowen, C., Ben-Arie, G., Shelef, I., Wandschneider, B., …, & Benninger, F. (2025). Imaging blood–brain barrier dysfunction in drug‐resistant epilepsy: A multi‐center feasibility study. Epilepsia, 66(1), 195-206. https://doi.org/10.1111/epi.18145

Vancouver

Cafri N, Mirloo S, Zarhin D, Kamintsky L, Serlin Y, Alhadeed L, et al. Imaging blood–brain barrier dysfunction in drug‐resistant epilepsy: A multi‐center feasibility study. Epilepsia. 2025;66(1):195-206. doi:10.1111/epi.18145

BibTeX
@article{Cafri2025,
  author = {Cafri, Nir and Mirloo, Sheida and Zarhin, Daniel and Kamintsky, Lyna and Serlin, Yonatan and Alhadeed, Laith and Goldberg, Ilan and Maclean, Mark A and Whatley, Ben and Urman, Ilia and Doherty, Colin P and Greene, Chris and Behan, Claire and Brennan, Declan and Campbell, Matthew and Bowen, Chris and Ben-Arie, Gal and Shelef, Ilan and Wandschneider, Britta and Koepp, Matthias and Friedman, Alon and Benninger, Felix},
  title = {Imaging blood–brain barrier dysfunction in drug‐resistant epilepsy: A multi‐center feasibility study},
  journal = {Epilepsia},
  year = {2025},
  volume = {66},
  number = {1},
  pages = {195--206},
  doi = {10.1111/epi.18145}
}
Kostenlos starten →